111 Capital Acquires Shares of 13,559 Option Care Health, Inc. (NASDAQ:OPCH)

111 Capital purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 13,559 shares of the company's stock, valued at approximately $315,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. JPMorgan Chase & Co. increased its holdings in Option Care Health by 29.6% in the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after acquiring an additional 344,875 shares during the last quarter. MetLife Investment Management LLC grew its stake in shares of Option Care Health by 7.8% in the 4th quarter. MetLife Investment Management LLC now owns 197,219 shares of the company's stock worth $4,575,000 after buying an additional 14,311 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Option Care Health by 6.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after buying an additional 147,054 shares in the last quarter. Global Alpha Capital Management Ltd. grew its stake in shares of Option Care Health by 38.1% in the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock worth $1,596,000 after buying an additional 18,992 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new position in shares of Option Care Health in the 4th quarter worth $327,000. 98.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have commented on OPCH. JPMorgan Chase & Co. lifted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Barrington Research reissued an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Wednesday, April 30th. JMP Securities reissued a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Trading Down 0.5%

Shares of OPCH stock traded down $0.16 during trading hours on Tuesday, reaching $31.70. 1,284,968 shares of the stock were exchanged, compared to its average volume of 1,864,035. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company's 50-day moving average price is $32.60 and its 200-day moving average price is $29.80. The firm has a market capitalization of $5.19 billion, a price-to-earnings ratio of 26.64, a price-to-earnings-growth ratio of 2.30 and a beta of 0.74.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. During the same period in the previous year, the company earned $0.26 EPS. The firm's revenue for the quarter was up 16.3% compared to the same quarter last year. As a group, equities analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.